Literature DB >> 24861436

Midterm results of hybrid perventricular closure of doubly committed subarterial ventricular septal defects in pediatric patients.

Da Zhu1, Ke Lin, Meng Lin Tang, Yuan Feng, Qi An.   

Abstract

OBJECTIVES: To evaluate the safety and efficiency of using hybrid perventricular closure in treating pediatric patients with the doubly committed subarterial ventricular septal defects (VSD).
METHODS: Ninety pediatric patients with doubly committed subarterial VSD were enrolled from October 2007 to September 2010 in this retrospective study. Among them, 41 underwent open-heart surgery (surgical group), while 49 underwent perventricular device closure (perventricular group).
RESULTS: There was no difference in age (4.36 ± 3.21 vs. 5.82 ± 4.32 years, p > 0.05) between the two groups. VSD diameter was significantly larger in the surgical group than in the perventricular group (5.03 ± 1.31 vs. 6.03 ± 1.94 mm, p < 0.05). There were no major complications such as death, severe valve insufficiency, significant residual shunt, or lethal arrhythmias in two groups. The perventricular group was associated with a significant reduction of transfusion rate (18.4% vs. 97.6%, p < 0.05) as well as mean intensive care unit (ICU) stay (0.97 ± 0.53 vs. 2.78 ± 3.00 days, p < 0.05) in comparison with the surgical group. No difference was noted for complete closure rate between two groups at discharge (97.6% vs. 85.7%, p > 0.05) as well as during follow-up (97.6% vs. 95.9%, p > 0.05). Perventricular device closure was not associated with an increased risk of procedure-induced aortic insufficiency compared with the open-heart surgical group during follow-up (14.3% vs. 14.6%, p > 0.05).
CONCLUSIONS: Hybrid perventricular closure may be an alternative to open-heart surgery in selected pediatric patients with doubly committed subarterial VSD.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24861436     DOI: 10.1111/jocs.12361

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

Review 1.  Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.

Authors:  David W Bearl; Gregory A Fleming
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

2.  Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results.

Authors:  Shu Zhang; Da Zhu; Qi An; Hong Tang; Dajiang Li; Ke Lin
Journal:  J Cardiothorac Surg       Date:  2015-09-15       Impact factor: 1.637

3.  Effects of transthoracic device closure on ventricular septal defects and reasons for conversion to open-heart surgery: A meta-analysis.

Authors:  Yang Zhou; Ling-Xi Liu; Fei Zhao; Shi-Hai Tang; Hua-Li Peng; Yun-Han Jiang
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

4.  A meta-analysis of perventricular device closure of doubly committed subarterial ventricular septal defects.

Authors:  Jiang-Shan Huang; Kai-Peng Sun; Shu-Ting Huang; Qiang Chen; Liang-Wan Chen; Yur-Ren Kuo
Journal:  J Cardiothorac Surg       Date:  2020-01-28       Impact factor: 1.637

5.  Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up.

Authors:  Long Wang; Lin Xie; Weiqiang Ruan; Tao Li; Changping Gan; Ke Lin
Journal:  BMC Surg       Date:  2020-09-18       Impact factor: 2.102

6.  Perventricular device closure of a doubly committed juxtaarterial ventricular septal defect through a left parasternal approach: midterm follow-up results.

Authors:  Li Hongxin; Guo Wenbin; Fei Liang; Hai-Zhou Zhang; Mei Zhu; Wen-Long Zhang
Journal:  J Cardiothorac Surg       Date:  2015-11-26       Impact factor: 1.637

7.  Intra-operative device closure of perimembranous ventricular septal defect without cardiopulmonary bypass under guidance of trans-epicardial echocardiography: a single center experience.

Authors:  Yong Sun; Peng Zhu; Pengyu Zhou; Yilong Guo; Shao-Yi Zheng
Journal:  J Cardiothorac Surg       Date:  2016-05-27       Impact factor: 1.637

Review 8.  Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects.

Authors:  P Syamasundar Rao; Andrea D Harris
Journal:  F1000Res       Date:  2018-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.